Email Updates

You are here

Home

2 JULY 2021 VOLUME 23 ISSUE 26

Media Coverage

  • The Instagram Account That Remembers the Human Story, and the Human Cost, of the HIV Crisis

    Since 2017, The AIDS Memorial has provided a platform that curates a collective memory. Its founder, Stuart, set it up with the very intention of remembrance. "It kind've just happened. Obviously if you're gay and of a certain age – of any age, really – the history is of interest. I did it for myself," he tells me over the phone on an afternoon when the brief British heatwave was at its most blistering. "People slowly engaged from there, and then started sending tributes to their loved ones on the back of that. It was really nice."

    July 1, 2021
    General
    Esquire

  • Kenya: Six-Month Standoff on ARVs Ends After Deal Struck

    The government has abandoned the demand that it should be the only one to distribute a Sh2.1 billion consignment of HIV drugs donated by the US, ending a six-month standoff on distribution of the anti-retroviral drugs.

    July 1, 2021
    Treatment
    All Africa

  • Research Into AIDS Cure Advancing but Remains in ‘Very Early Days’

    Unlike the coronavirus, the AIDS virus’s ability to permanently infect the human body has made it more difficult to develop an AIDS vaccine, and research into a cure for HIV/AIDS is continuing to advance but remains in its “very early days,” according to Carl W. Dieffenbach, who has served for the past 25 years as director of the National Institutes of Health’s Division of AIDS.

    July 1, 2021
    Cure
    Washington Blade

  • ‘Gamechanger’: HIV Transmission Dropped 90 Percent for Men Taking PrEP, Australian Study Finds

    Nearly 10,000 gay and bisexual men in New South Wales who took the HIV prevention drug PrEP as part of a three-year trial had a transmission rate 90 percent lower than otherwise expected, a new study has found.

    July 1, 2021
    PrEP
    The Guardian

  • Needle Exchanges Are a Proven Tool To Fight HIV, but Officials Still Want To Shut Them Down

    While COVID-19 raged in the United States, a set of public health crises was pushed to the background. HIV and drug use flourished during the pandemic, fueled in part by extended isolation and economic fallout. Relapses were commonplace and services harder to access. Now, as the US emerges from the worst of its outbreak, it's grappling with pockets of HIV linked to sharing needles.

    June 30, 2021
    General
    ABC News

  • Gilead Challenges ViiV in Resistant HIV, Filing Twice-Yearly Therapy

    Gilead Sciences has filed for FDA approval of a long-acting therapy for resistant HIV infections that only needs to be administered once every six months.

    June 29, 2021
    Treatment
    PharmaPhorum

  • Once-Promising Vaccine Regimen Fails to Prevent HIV

    An experimental vaccine regimen did not protect people from acquiring HIV in a large clinical trial in South Africa, an international team of scientists reported recently in The New England Journal of Medicine. These results add to a long string of disappointments in HIV vaccine research.

    June 29, 2021
    HIV Vaccine
    POZ

  • AIDS Disappeared From Public View Without Ending. Will COVID-19 Do the Same?

    As 2021’s Pride Month comes to a close amid the continuing coronavirus pandemic, we should think about what it means to live through a pandemic that is fading from public view, even as it shapes and shortens the lives of vulnerable people.

    June 29, 2021
    General
    Washington Post

  • Opinion: US Leadership Matters in Fighting AIDS

    US President Joe Biden has repeatedly praised the United States’ leadership in the global effort to end HIV/AIDS. Early this month, in marking the 40th anniversary of the start of the AIDS pandemic, the White House noted the “heartbreaking human toll” of nearly 35 million global AIDS deaths, the ongoing, high rate of new HIV infections worldwide, and the enormous progress being made against the epidemic by the US President’s Emergency Plan for AIDS Relief, or PEPFAR.

    June 28, 2021
    General
    Devex

  • Trial Offering PrEP to Women in South Africa Halves HIV Incidence

    An HIV prevention trial involving women in South Africa that began offering PrEP in its final year found HIV incidence halved among participants, despite only one in four taking it.

    June 28, 2021
    PrEP
    Avert

  • Are Scientists Getting Closer to an HIV Cure?

    Twenty-five years ago this fall, effective treatment for HIV became a reality. The first class of HIV drugs that was approved, the NRTIs, had worked to a degree, but even using two NRTIs together, they were quickly outsmarted by the ever-mutating virus. Then, in 1996, two new classes of HIV drugs were approved: the protease inhibitors (PIs) and the NNRTIs. Combining two NRTIs with either a PI or an NNRTI to arrive at the appropriate antiretroviral therapy (ART) regimen did the trick.

    June 28, 2021
    Cure
    The Body

  • Can HIV Treatment Prevent All Transmission of the Virus?

    Back in 1988, Myron “Mike” Cohen, MD, of the University of North Carolina (UNC), was studying the presence of gonorrhea in the genital tract when he had a conversation with a scientist at a party that would change the course of his career and the lives of people living with HIV.

    June 28, 2021
    Treatment
    POZ

  • Study Shows a Huge Burden of Undiagnosed Disease in a Rural South African District

    South Africa’s massive effort over the years to test and treat people for HIV has drastically improved public health. But in that process, other diseases that are highly prevalent may have been neglected.

    June 27, 2021
    General
    The Conversation

  • Once-a-Month HIV PrEP Could Be the Future and Replace Daily Pills

    Women who are at risk of HIV infection and are using HIV pre-exposure prophylaxis (PrEP) on a daily basis might in the near future have to use only one pill a month, if a trial conducted in SA and other parts of the world is successful.

    June 26, 2021
    PrEP
    Sowetan Live

  • India’s Healthcare System Is Still Failing Queer‑Trans People. A Public Health Movement Can Change That

    In 1994, doctors associated with the AIDS control program in Delhi were attending to inmates of the Tihar Jail and found a large number of inmates engaging in “homosexual acts.” The doctors demanded that condoms be distributed to inmates of the prison. Kiran Bedi, the then Inspector General (Prisons), Delhi, was flabbergasted and held the ground that distributing condoms to the inmates will only serve towards encouraging “immoral behavior.”

    June 26, 2021
    General
    The Swaddle

Published Research

Announcements